Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

  • dojothegreat33 dojothegreat33 Feb 27, 2013 8:17 AM Flag

    More Hot Air

     

    As many of you know, we have been waiting patiently for the NIH to issue revised guidelines that would qualify our company’s hESC lines for federal funding, possibly opening up new sources of support for some of our programs, as well permit academic collaborators to use our hESC lines to develop cell therapy products for treating other significant diseases. All that seemed to stand in the way of the new guidelines was this court case. We can now look forward to 2013 being the year that we can finally provide our clinical grade stem cell lines to many other therapeutic development programs and more broadly introduce the world to the concept that embryonic stem cells can be made without any harm to embryos. A bold message, perhaps now about to become more meaningful through the ability of the hundreds of NIH funded university and medical school laboratories involved in cell therapy research to finally have meaningful access to our stem cell lines and with that, a more streamlined (and less costly) timeline for their preclinical programs.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
ACTC
0.00(0.00%)